Compare CNC & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNC | LH |
|---|---|---|
| Founded | 1984 | 1971 |
| Country | United States | United States |
| Employees | N/A | 70000 |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 21.7B |
| IPO Year | 2001 | 2005 |
| Metric | CNC | LH |
|---|---|---|
| Price | $58.31 | $256.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | $46.75 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 6.2M | 705.0K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | 3.11 | ★ 3.35 |
| Revenue | ★ $194,777,000,000.00 | $13,951,700,000.00 |
| Revenue This Year | $8.31 | $8.26 |
| Revenue Next Year | $1.05 | $4.81 |
| P/E Ratio | ★ $18.68 | $75.04 |
| Revenue Growth | ★ 19.44 | 7.25 |
| 52 Week Low | $25.08 | $239.75 |
| 52 Week High | $62.21 | $293.72 |
| Indicator | CNC | LH |
|---|---|---|
| Relative Strength Index (RSI) | 79.93 | 44.16 |
| Support Level | $33.00 | $247.44 |
| Resistance Level | N/A | $275.06 |
| Average True Range (ATR) | 1.98 | 6.31 |
| MACD | 0.22 | -0.03 |
| Stochastic Oscillator | 83.83 | 42.25 |
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.